A post COVID‐19 ‘Marshall Plan’ for type 2 diabetes

Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018

(2020) Chintan V. Dave et al.   DIABETES CARE

Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank

(2020) Claire L. Niedzwiedz et al.   BMC Medicine

Socio-economic differences in cardiovascular disease risk factor prevalence in people with type 2 diabetes in Scotland: a cross-sectional study

(2020) E. Whittaker et al.   DIABETIC MEDICINE

Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review

(2020) Awadhesh Kumar Singh et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial

(2019) Michael E J Lean et al.   Lancet Diabetes & Endocrinology

Type 2 diabetes remission: economic evaluation of the Di RECT /Counterweight‐Plus weight management programme within a primary care randomized controlled trial

(2019) Y. Xin et al.   DIABETIC MEDICINE

One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot

(2018) O. Binns-Hall et al.   DIABETIC MEDICINE

Trends in recorded capillary blood glucose and hypoglycaemia in hospitalised patients with diabetes

(2014) G.C. Jones et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

(2011) L. Govan et al.   DIABETOLOGIA

Diabetic Retinopathy: More Patients, Less Laser: A longitudinal population-based study in Tayside, Scotland

(2008) J. H. Vallance et al.   DIABETES CARE